At the preclinical level, in vitro, quercetin inhibits hypoxia-related HIF-1α protein accumulation and VEGF release in breast cancer cell lines primarily through inhibition of HIF-1α protein synthesis [63]. This evidence concerns the gene VEGFA and breast carcinoma.